Clinical Trial Update: Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection [Phase 2]

View source ↗

Summary

Phase 2 trial suggesting conversion to Envarsus post-kidney transplant may reduce BK infection risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Infection
• Renal Transplant Complications

Drugs mentioned

• Envarsus (tacrolimus)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Renal Transplant Infection | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27